Abstract

Background: Early diagnosis is essential to improve the treatment and prognosis of newborn infants with nosocomial bacterial infections. Although cytokines and procalcitonin (PCT) have been evaluated as early inflammatory markers, their diagnostic properties have rarely been compared.Objectives: This study evaluated and compared the ability of individual inflammatory markers available for clinician (PCT, semi-quantitative determination of IL-8) and of combinations of markers (CRPi plus IL-6 or quantitative or semi-quantitative determination of IL-8) to diagnose bacterial nosocomial infections in neonates.Methods: This prospective two-center study included neonates suspected of nosocomial infections from September 2008 to January 2012. Inflammatory markers were measured initially upon suspicion of nosocomial infection, and CRP was again measured 12–24 h later. Newborns were retrospectively classified into two groups: those who were infected (certainly or probably) and uninfected (certainly or probably).Results: The study included 130 infants of median gestational age 28 weeks (range, 24–41 weeks). Of these, 34 were classified as infected and 96 as uninfected. The sensitivity, specificity, positive and negative predictive values (PPV and NPV), and positive and negative likelihood ratios (LR+ and LR-) for PCT were 59.3% (95% confidence interval [CI], 38.8–77.6%), 78.5% (95% CI, 67.8–86.9%), 48.5% (95% CI, 30.8–66.5%), 84.9% (95% CI, 74.6–92.2%), 2.7 (95% CI, 1.6–4.9), and 0.5 (95% CI, 0.3–0.8), respectively. Semi-quantitative IL-8 had the highest specificity (92.19%; 95% CI, 82.70–97.41%), PPV (72.22%; 95% CI, 46.52–90.30%) and LR+ (6.17, 95% CI, 2.67–28.44), but had low specificity (48.15%; 95% CI, 28.67–68.05%). Of all markers tested, the combination of IL-6 and CRPi had the highest sensitivity (78.12%; 95% CI, 60.03–90.72%), NPV (91.3%; 95% CI, 82.38–96.32%) and LR- (0.29; 95% CI, 0.12–0.49). The combination of IL-6 and CRPi had a higher area under the curve than PCT, but with borderline significance (p = 0.055).Conclusions: The combination of IL-6 and CRPi was superior to other methods, including PCT, for the early diagnosis of nosocomial infection in neonates, but was not sufficient for sole use. The semi-quantitative determination of IL-8 had good diagnostic properties but its sensitivity was too low for use in clinical practice.

Highlights

  • Nosocomial bacterial infection (NBI) increases mortality and morbidity in neonates, especially in very low birth weight or extremely preterm newborn infants

  • Newborn infants were excluded if they were in early postoperative phase (

  • Semi-quantitative IL-8 and PCT were measured at the time of measurement of IL-6 and/or quantitative IL-8 and initial C-reactive protein (CRP) (CRPi). assays usually performed in patients with suspected infection at each center

Read more

Summary

Introduction

Nosocomial bacterial infection (NBI) increases mortality and morbidity in neonates, especially in very low birth weight or extremely preterm newborn infants. Owing to the possible severity of NBI, antibiotic treatment is frequently initiated immediately in neonates with a suspected diagnosis of NBI This strategy, results in the exposure of a large number of newborn infants to needless antibiotic administration, carries a potential risk for the selection in these patients of multiple drug-resistant bacteria and increases health care costs. Recommendations of the Evidence Based Medicine Working Group [6] have attempted to standardize the methodology of studies evaluating diagnostic markers. These include the need for blinded comparisons; the inclusion in the study population of patients to whom these tests are applicable in clinical practice; and the reporting of the diagnostic properties of these markers as likelihood ratios to assess at best their clinical value. Cytokines and procalcitonin (PCT) have been evaluated as early inflammatory markers, their diagnostic properties have rarely been compared

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call